These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36227222)

  • 1. Menthol augmented niosomes for enhanced intestinal absorption of lopinavir.
    Fayed ND; Essa EA; El Maghraby GM
    Pharm Dev Technol; 2022 Nov; 27(9):956-964. PubMed ID: 36227222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lopinavir-menthol co-crystals for enhanced dissolution rate and intestinal absorption.
    Fayed ND; Arafa MF; Essa EA; El Maghraby GM
    J Drug Deliv Sci Technol; 2022 Aug; 74():103587. PubMed ID: 35845293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Niosomes for oral delivery of nateglinide: in situ-in vivo correlation.
    Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
    J Liposome Res; 2018 Sep; 28(3):209-217. PubMed ID: 28618876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colloidal carriers for extended absorption window of furosemide.
    Sultan AA; El-Gizawy SA; Osman MA; El Maghraby GM
    J Pharm Pharmacol; 2016 Mar; 68(3):324-32. PubMed ID: 26773855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterisation of Span 65 niosomal formulations containing proteins.
    Haj-Ahmad RR; Elkordy AA; Chaw CS
    Curr Drug Deliv; 2015; 12(5):628-39. PubMed ID: 25963305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentials of proniosomes for improving the oral bioavailability of poorly water-soluble drugs.
    Song S; Tian B; Chen F; Zhang W; Pan Y; Zhang Q; Yang X; Pan W
    Drug Dev Ind Pharm; 2015 Jan; 41(1):51-62. PubMed ID: 24111828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge.
    Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S
    Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Formulation of niosomal gel for enhanced transdermal lopinavir delivery and its comparative evaluation with ethosomal gel.
    Patel KK; Kumar P; Thakkar HP
    AAPS PharmSciTech; 2012 Dec; 13(4):1502-10. PubMed ID: 23104306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential oils in niosomes for enhanced transdermal delivery of felodipine.
    Eid RK; Essa EA; El Maghraby GM
    Pharm Dev Technol; 2019 Feb; 24(2):157-165. PubMed ID: 29441809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and Evaluation of Niosomal in situ Nasal Gel of a Serotonin Receptor Agonist, Buspirone Hydrochloride for the Brain Delivery via Intranasal Route.
    Mathure D; Madan JR; Gujar KN; Tupsamundre A; Ranpise HA; Dua K
    Pharm Nanotechnol; 2018; 6(1):69-78. PubMed ID: 29380709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
    Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and characterization of drug loaded nonionic surfactant vesicles (niosomes) for oral bioavailability enhancement.
    Kamboj S; Saini V; Bala S
    ScientificWorldJournal; 2014; 2014():959741. PubMed ID: 24672401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Peceol™/Span™ 60 Niosomes Coated with Chitosan for Candesartan Cilexetil: Perspective Increase in Absolute Bioavailability in Rats.
    AbuElfadl A; Boughdady M; Meshali M
    Int J Nanomedicine; 2021; 16():5581-5601. PubMed ID: 34429601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cubosomes for Enhancing Intestinal Absorption of Fexofenadine Hydrochloride: In situ and in vivo Investigation.
    Sultan AA; El Nashar NF; Ashmawy SM; El Maghraby GM
    Int J Nanomedicine; 2022; 17():3543-3560. PubMed ID: 35983479
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
    Guinedi AS; Mortada ND; Mansour S; Hathout RM
    Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and characterization of ofloxacin niosomes.
    Ramalingam N; Natesan G; Dhandayuthapani B; Perumal P; Balasundaram J; Natesan S
    Pak J Pharm Sci; 2013 Nov; 26(6):1089-96. PubMed ID: 24191311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Permeation enhancers loaded bilosomes for improved intestinal absorption and cytotoxic activity of doxorubicin.
    Sultan AA; Saad GA; El Maghraby GM
    Int J Pharm; 2023 Jan; 630():122427. PubMed ID: 36435504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of EP-liposomes and Span 40-niosomes.
    Ning M; Guo Y; Pan H; Zong S; Gu Z
    Pharmazie; 2006 Mar; 61(3):208-12. PubMed ID: 16599261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: application of Box-Behnken design, in-vitro evaluation and in-vivo skin deposition study.
    Abdelbary AA; AbouGhaly MH
    Int J Pharm; 2015 May; 485(1-2):235-43. PubMed ID: 25773359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surfactant vesicles for enhanced antitoxoplasmic effect of norfloxacin: In vitro and in vivo evaluations.
    Eid RK; Arafa MF; Ashour DS; Essa EA; El-Wakil ES; Younis SS; El Maghraby GM
    Int J Pharm; 2023 May; 638():122912. PubMed ID: 37015296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.